Positron Emission Tomography Market: Market Size & Forecast 2026

The global PET scanner market encompasses the manufacture, distribution, and servicing of PET imaging systems, including standalone PET scanners and hybrid PET/CT and PET/MRI systems used in hospitals, imaging centers, and research institutions. Revenue streams also include radiotracer production, software solutions, and aftermarket service contracts. The market has matured considerably over the past two decades, with technology advancements shifting toward digital detectors, faster scan times, and improved image resolution, all of which contribute to better patient outcomes and higher clinical adoption rates.

• •PET scanners use cyclotron-produced radiotracers (most commonly FDG, or fluorodeoxyglucose) to generate three-dimensional images of functional processes in the body
• •Hybrid PET/CT systems dominate the market due to their ability to combine anatomical and functional imaging in a single examination
• •The market includes OEM manufacturers, radiotracer suppliers, and a growing ecosystem of AI-powered image analysis software providers

The primary catalyst for market expansion is the global rise in cancer incidence, which has driven demand for PET imaging in oncology for diagnosis, staging, restaging, and therapy response assessment. Technological progress, including the transition from analog to digital detectors, has reduced scan times, improved sensitivity, and lowered radiation doses, making PET more accessible and appealing to clinicians. Additionally, the development of novel, disease-specific radiotracers, such as those targeting prostate cancer, Alzheimer's disease, and neuroendocrine tumors, is expanding PET's clinical utility beyond its traditional oncology stronghold.

• •The World Health Organization estimates global cancer cases continue to rise, directly increasing demand for PET-based diagnostic and monitoring procedures
• •Approval of new radiotracers by regulatory agencies like the FDA and EMA is opening new clinical indications and driving adoption
• •Government and institutional investments in nuclear medicine infrastructure, particularly in developing economies, are expanding market reach

The market is segmented by product type into standalone PET systems, PET/CT systems (which hold the largest market share), and PET/MRI systems (the fastest-growing segment due to superior soft-tissue contrast and reduced radiation exposure). Geographically, North America leads the market, supported by advanced healthcare infrastructure, favorable reimbursement policies, and high cancer prevalence. Europe follows closely, while the Asia-Pacific region is the fastest-growing market, fueled by rising healthcare spending, increasing disease burden, and government initiatives to expand nuclear medicine capabilities.

• •PET/CT systems account for the majority of installations globally, while PET/MRI adoption is accelerating in academic and research medical centers
• •North America held approximately 40% of the global market share in recent years, with the U.S. being the dominant contributor
• •Asia-Pacific markets, particularly China, India, and Japan, are expanding rapidly as local manufacturing capabilities and healthcare access improve

What are the recent trends and outlook?

Key trends shaping the future of the PET market include the integration of artificial intelligence and deep learning algorithms for automated image reconstruction, lesion detection, and quantitative analysis, which are improving diagnostic accuracy and workflow efficiency. Total-body PET scanners, capable of imaging the entire human body simultaneously, represent a revolutionary advancement offering dramatically improved sensitivity and the potential to discover new clinical applications. Additionally, the industry is moving toward more decentralized radiotracer production using compact cyclotrons located closer to patients, which could reduce supply chain constraints and improve access to PET imaging in underserved regions.

• •AI-assisted PET image reconstruction and analysis tools are being rapidly adopted to reduce radiologist workload and improve reproducibility of quantitative measurements
• •Total-body PET technology, with extended axial field-of-view scanners, is expected to create new clinical research opportunities and potentially expand routine clinical indications
• •Theranostic approaches combining diagnostic PET imaging with targeted radionuclide therapy are emerging as a significant growth area, particularly in neuroendocrine tumors and prostate cancer